L'Oréal Doesn't Buy Brands. It Buys Empty Rungs on a Ladder It Already Built.
Everyone counts L'Oréal's 37 brands and calls it a portfolio. The real asset is a four-division price ladder so precise that buying CeraVe for $1.3B or Aesop for $2.525B is just sliding a new brand into a rung the machine already runs.
Comes with a free Adjacency / Synergy Map template — plus a worked example for L'Oreal.
In 2017, L'Oréal paid $1.3 billion for CeraVe — a no-frills American moisturizer sold off pharmacy shelves, beloved by dermatologists and nobody's idea of glamour. Four years later it was doing $1 billion a year, and it went on to become the number-one skincare brand in the United States.7 The instinct is to call this a great bet on a great brand. It wasn't, mostly. CeraVe walked into a machine that already knew exactly where to put it — a division built for pharmacy-channel dermatological skincare, with the R&D, the regulatory muscle, and the distribution already running. L'Oréal didn't buy a brand. It bought a brand that fit a rung it had left empty for years.
The official story of L'Oréal is a story about brands: 37 of them, a sprawling collection of names that lets the company sell to everyone.1 That framing makes it sound like a junk drawer of beauty labels. The real asset is not the count. It is the shape — a four-division price ladder so disciplined that L'Oréal can acquire almost any brand, at almost any price point, and know in advance which channel will carry it, which lab will improve it, and which existing brands it will sit politely between without eating their lunch.
Four divisions, one ladder, no overlap
L'Oréal calls it the 'multipolar model': four strategic divisions — Consumer Products, L'Oréal Luxe, Professional Products, and Dermatological Beauty — each owning a distinct slice of how and where beauty is bought.2 This isn't an org chart for tidiness. It is a map of price points and channels. Mass-market makeup sits in Consumer Products and flows through drugstores and supermarkets. Prestige flows through department stores and travel retail in L'Oréal Luxe. Salon products run through hairdressers in Professional. And the science-led skincare — Vichy, La Roche-Posay, CeraVe — moves through pharmacies in Dermatological Beauty. Each division is a finished pipe with its own customers, its own sales force, and its own logic. The brands are interchangeable cartridges; the pipes are the moat.
| Division | Where it sells | What it buys |
|---|---|---|
| Consumer Products | Drugstores, supermarkets, mass retail | Maybelline, mass-market makeup |
| L'Oréal Luxe | Department stores, travel retail | Lancôme, Aesop, YSL Beauté |
| Professional Products | Hair salons, stylists | Salon-channel haircare |
| Dermatological Beauty | Pharmacies, dermatologists | CeraVe, La Roche-Posay, Vichy |
This architecture is old. L'Oréal went public in 1963, bought Lancôme in 1964 and Garnier in 1965, and those two moves seeded the divisional logic that still runs the company six decades later.3 Lancôme gave it a foothold in prestige; Garnier deepened the mass channel. The legend that Lancôme was acquired as an ancient luxury house is generous — it was less than thirty years old when L'Oréal bought it, and most of its global prestige was built afterward, by L'Oréal's own investment. That is the tell. The company doesn't buy finished empires. It buys promising occupants for rooms it has already built.
What L'Oréal is actually paying for
Watch the acquisitions and the pattern is unmistakable. In 1996 it won a bidding war for Maybelline against Germany's Benckiser, with a final tender offer of roughly $43.93 a share — around $570 million in equity plus some $150 million of assumed debt — and instantly became the world leader in mass-market makeup.45 Maybelline didn't need a new factory or a new shelf; it needed L'Oréal's Consumer Products pipe, into which it dropped like a key into a lock. Twenty-seven years later, the company paid an enterprise value of $2.525 billion for Aesop — its largest-ever brand deal, eclipsing the $1.7 billion YSL Beauté acquisition of 2008.6 Aesop, on roughly $537 million of 2022 sales, was expensive on every multiple. But it slotted cleanly into L'Oréal Luxe, the division that became the global number-one in luxury beauty and threw off around €3.33 billion in operating profit in 2023.68
Notice the detail that gets the credit wrong everywhere. Aesop is called an 'Australian brand' — it was founded in Melbourne — but L'Oréal didn't buy it from Australian founders. It bought it from Natura & Co, the Brazilian parent that had owned it outright.6 The provenance is irrelevant to L'Oréal's logic, which is exactly the point: the brand's origin story is the cartridge; the only question that matters is which pipe it fits.
CeraVe cost $1.3 billion and hit $1 billion in annual sales within four years, because the dermatological-beauty pipe — pharmacy distribution, clinical credibility, R&D — was already built and waiting.7 The acquirer who buys the brand alone pays for the brand alone. L'Oréal pays for the brand and then multiplies it through machinery a rival would have to build from scratch.
Why a rival can't just go shopping
The obvious objection: anyone with a checkbook can buy brands. Private equity does it constantly. So where is the moat? The moat is that buying brands is the easy half, and the half that doesn't compound. A roll-up that acquires ten beauty labels owns ten separate distribution problems, ten R&D budgets, ten sales forces, and ten brands competing for the same shelf. L'Oréal owns four pipes that have run for decades, each finely calibrated so its brands address different price points and channels — and crucially, so a new brand can be slotted in without cannibalizing the ones above and below it.2 When CeraVe joined Dermatological Beauty, it didn't bleed La Roche-Posay; it occupied an adjacent, vacant position. That non-cannibalizing precision is the thing money can't shortcut, because it is the product of sixty years of building the ladder one rung at a time.
The honest counter is that the model has a ceiling and a risk. The ceiling: pay too much for the occupant and even a perfect pipe can't make the math work — Aesop at $2.525 billion on $537 million of sales is a wager that only the L'Oréal Luxe machine can justify, and if it can't, the discipline was just expensive optimism.6 The risk: ladders assume the rungs stay where you put them. Direct-to-consumer brands that sell through Instagram, not pharmacies or department stores, can scale without ever entering one of L'Oréal's four pipes — which is precisely why L'Oréal keeps acquiring them, to pull them back onto the ladder before they prove the ladder optional. The defense is real, but it is a defense, not a guarantee.
The reason most acquisition strategies disappoint is that they pay full price for a brand and then have to build the distribution, R&D, and scale that turn a brand into a business. The durable version inverts it: build the machinery first — the channels, the pipelines, the price-tier discipline — and acquire only the brands that snap into a rung you've already engineered. Then your price isn't 'what the brand is worth standing alone'; it's 'what the brand is worth multiplied through infrastructure your rival would need a decade to copy.' Two cautions: don't let a perfect pipe seduce you into overpaying for the occupant, and watch for channels that route around your ladder entirely — when buyers stop using the pipes you own, owning the pipes stops being a moat.
L'Oréal looks like a company that collects brands. It is closer to a company that built a four-lane road decades ago and now charges admission to anyone who wants to drive on it — except it owns the cars too, and buys new ones only when there's an empty lane. The 37 brands are not the achievement.1 The achievement is that when the next CeraVe or Aesop comes up for sale, L'Oréal already knows where it goes, what it costs to run, and whom it sits beside. The genius was never the shopping. It was building the place everything it buys was always going to fit.
More companies that win by owning the structure, not the product
Adjacency / Synergy Map
A one-page canvas for an adjacency play: the new business next door, the shared assets that justify entering it, the synergies that actually transfer versus the ones that evaporate on contact, and the dis-synergies nobody put on the deck. Blank to test your own expansion; filled as the worked example showing where the story's 'natural adjacency' was real and where it was wishful.
The worked example unlocks with a subscription. See plans →
Sources
Where this comes from — the filings, records, and reporting behind it.
- 1L'Oréal 2023 full-year sales of €41.18 billion; portfolio of 37 international brands; more than 90,000 employees; distributed across all channels including mass market, department stores, pharmacies, hair salons, and travel retail.
- 2L'Oréal operates four strategic divisions — Consumer Products, L'Oréal Luxe, Professional Products, and Dermatological Beauty — described by the company as its 'multipolar model' enabling coverage of all aspects of beauty across all distribution channels.
- 3L'Oréal went public in 1963 (Paris Bourse) and acquired Lancôme in 1964 and Laboratoires Garnier in 1965, creating the divisional structure that persists today.
- 4L'Oréal acquired Maybelline in 1996, becoming the world leader in mass-market makeup. The acquisition involved a bidding war; L'Oréal's final tender offer was approximately $43.93/share (~$570M equity, plus ~$150M assumed debt per contemporaneous press). Often cited as '$758M total' or '$660M' — figures differ by whether debt assumption is included.
- 5UPI contemporaneous wire (January 19, 1996) confirms L'Oréal's final Maybelline bid was $570 million ($41/share equity), and that L'Oréal would assume ~$150M in Maybelline debt, in competition with Germany's Benckiser.
- 6L'Oréal acquired Aesop from Brazilian parent Natura & Co in April 2023 at an enterprise value of $2.525 billion (Aesop's 2022 sales: $537M). This is L'Oréal's largest-ever brand acquisition, surpassing the $1.7B YSL Beauté deal of 2008.
- 7CeraVe was acquired by L'Oréal for $1.3 billion in 2017 and reached $1 billion in sales in 2021, later becoming the #1 skincare brand in the US.
- 8L'Oréal Luxe division generated approximately €3.33 billion in operating profit in 2023 and became the global number-one in luxury beauty, growing +4.5% like-for-like.